HER2-POSITIVE BREAST CARCINOMA
Clinical trials for HER2-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer breakthrough: Surgery-Free option for exceptional responders?
Disease control Recruiting nowThis study is testing whether women with certain types of breast cancer (HER2-positive or triple-negative) who have no cancer left after initial drug therapy can safely skip surgery and just receive radiation. For others with ER-positive/HER2-negative cancer, it tests skipping ra…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for advanced cancers with DNA repair flaws: PARP inhibitor trial opens
Disease control Recruiting nowThis study tests the drug talazoparib in adults with advanced solid tumors (like breast, prostate, ovarian, pancreatic, or stomach cancer) that have certain gene changes affecting DNA repair. The drug blocks a protein called PARP, which cancer cells need to fix their DNA, potenti…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
AI-Powered scans could spare breast cancer patients from unnecessary surgery
Knowledge-focused Recruiting nowThis study tests whether a special PET/MRI scan, analyzed by artificial intelligence, can accurately tell if HER2-positive breast cancer has been completely eliminated by chemotherapy before surgery. About 460 women will get three scans over their treatment. If successful, this a…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated May 17, 2026 03:13 UTC
-
Breast cancer drugs may raise diabetes risk – new study investigates
Knowledge-focused Recruiting nowThis study looks at how hormone treatments for breast cancer (aromatase inhibitors and tamoxifen) affect blood sugar control and diabetes risk in postmenopausal women. Researchers will compare blood sugar measures in women taking these drugs to healthy women not on treatment. The…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC
-
Mayo clinic study seeks immune clues in HER2 breast cancer patients
Knowledge-focused Recruiting nowThis study collects blood and tumor tissue from 230 adults with HER2-positive breast cancer (stages I-IV) who are starting anti-HER2 drugs like trastuzumab. Researchers want to learn how the immune system responds to these treatments. The goal is to better understand the connecti…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC